Irland - engelsk - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - tolterodine tartrate - prolonged-release capsule, hard - 2 milligram(s) - drugs for urinary frequency and incontinence; tolterodine

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

durbin plc - ferrous gluconate; folic acid - modified-release tablet - 250mg ; 4mg

Irland - engelsk - HPRA (Health Products Regulatory Authority)

pharmathen s.a. - galantamine hydrobromide - prolonged release capsules - 8 milligram

Irland - engelsk - HPRA (Health Products Regulatory Authority)

pharmathen s.a. - galantamine hydrobromide - prolonged release capsules - 16 milligram

Irland - engelsk - HPRA (Health Products Regulatory Authority)

pharmathen s.a. - galantamine hydrobromide - prolonged release capsules - 24 milligram

Irland - engelsk - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd t/a gerard laboratories - tolterodine tartrate - prolonged release capsules - 4 milligram - drugs for urinary frequency and incontinence

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - azathioprine, quantity: 50 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; lactose monohydrate; hypromellose; magnesium stearate; maize starch; stearic acid; macrogol 400 - imuran is used as an immunosuppressant antimetabolite either alone, or more commonly in combination with other agents (usually corticosteroids) and procedures which influence the immune response. therapeutic effect may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with high dosage and prolonged usage of corticosteroids. imuran, in combination with corticosteroids and/or other immunosuppressive agents and procedures, is indicated in the management of patients receiving organ transplants. imuran, either alone or more usually in combination with corticosteroids and/or other procedures, has been used with clinical benefit which may include reduction of dosage or discontinuation of corticosteroids, in a proportion of patients suffering from the following; severe rheumatoid arthritis; systemic lupus erythematosus; dermatomyositis/polymyositis; autoimmune chronic active hepatitis; pemphigus vulgaris; polyarteritis nodosa; autoimmune haemolyti

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - azathioprine, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; maize starch; magnesium stearate; stearic acid; iron oxide yellow; iron oxide red; hypromellose; titanium dioxide; macrogol 400 - imuran is used as an immunosuppressant antimetabolite either alone, or more commonly, in combination with other agents (usually corticosteroids) and procedures which influence the immune system response. therapeutic effect may be evident only after weeks or months & can include a steroid-sparing effect, thereby reducing the toxocity associated with high dosage and prolonged usage of corticosteroids. imuran, in combination with corticosteroids and/or other immunosuppressive agents and procedures, is indicated in the management of patients receiving organ transplants. imuran, either alone or more usually in combination with corticosteroids and/or other procedures, has been used with clinical benefit which may include reduction of dosage or discontinuation of corticosteroids, in a proportion of patients suffering from the following: severe rheumatoid arthritis; systemic lupus erythematosus; dermatomyositis/polymyositis; autoimmune chronic active hepatitis; pemphigus vulgaris; polyarteritis nodosa; autoimmune hae

Irland - engelsk - HPRA (Health Products Regulatory Authority)

shire pharmaceuticals ireland limited - galantamine hydrobromide - capsule, hard - 8 milligram(s) - anticholinesterases; galantamine

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - lercanidipine hydrochloride, quantity: 10 mg; enalapril maleate, quantity: 20 mg - tablet, film coated - excipient ingredients: lactose monohydrate; sodium bicarbonate; purified talc; quinoline yellow aluminium lake; sodium starch glycollate type a; iron oxide yellow; magnesium stearate; microcrystalline cellulose; hypromellose; titanium dioxide; povidone; macrogol 6000 - treatment of hypertension. treatment should not be initiated with these fixed dose combinations. (see dosage and administration).